Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \> 18 years old~* cancer diagnosis~* GFR \< 60 and \> 30 ml/min/1,73m2 by MDRD formula or diabetic~* CT with contrast~Exclusion Criteria:~* dialysis needed~* uncontrolled hypertension~* changes in serum creatinine levels of at least 0.5 mg/dl during the previous 24 hours of procedure~* recent exposure to radiographic contrast agents (within previous two days of the study)~* administration of dopamine, mannitol , fenoldopam or N-Acetyl Cystein during the intended time of study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- sodium bicarbonate (Type: ACTIVE_COMPARATOR): Solution 154 mEq/L of sodium bicarbonate
- Sodium chloride (Type: ACTIVE_COMPARATOR): Solution of 154 mEq/L of NaCl

Based on this trial design, predict the completion outcome and termination type (if applicable).